Fetal fraction is the percentage of cell-free DNA in a pregnant person’s blood that comes from the placenta rather than the mother. When you get noninvasive prenatal testing (NIPT), the lab measures this number to determine whether there’s enough placental DNA in your blood sample to produce a reliable result. Between 10 and 20 weeks of pregnancy, the average fetal fraction is 10% to 15%, and most labs require a minimum of about 4% to report results.
Where “Fetal” DNA Actually Comes From
Despite the name, fetal fraction DNA doesn’t come directly from the fetus. It comes from the placenta. The outer layer of the placenta, called the trophoblast, constantly renews itself throughout pregnancy. As old cells break down through a natural recycling process, they release tiny fragments of DNA into the mother’s bloodstream. These fragments mix with the mother’s own cell-free DNA, which is shed from her cells in a similar way.
Fetal fraction is simply the ratio: the amount of placental DNA divided by the total amount of cell-free DNA (both maternal and placental) in a blood sample. If your sample contains 12% fetal fraction, that means 12% of all the free-floating DNA fragments in your blood originated from the placenta, and the remaining 88% came from your own cells.
Why Fetal Fraction Matters for NIPT
NIPT works by analyzing those tiny DNA fragments to look for extra or missing chromosomes. But the placental DNA is heavily outnumbered by maternal DNA in every sample. If the fetal fraction is too low, the signal from the placental DNA gets lost in the noise, and the lab can’t distinguish a normal result from an abnormal one. This is why labs set a minimum threshold, typically around 4%, below which they won’t issue a result.
A sample that falls below this cutoff produces what’s called a “no-call” result, meaning the test is inconclusive. This isn’t a positive or negative finding. It simply means the lab couldn’t gather enough information to make a call. The American College of Obstetricians and Gynecologists recommends that people who receive a no-call result be offered genetic counseling, a detailed ultrasound, and the option of diagnostic testing such as amniocentesis, because a failed test carries a slightly higher statistical chance of certain chromosomal conditions.
What Affects Your Fetal Fraction
Two factors have the strongest influence on fetal fraction: how far along you are in pregnancy and your body weight.
Gestational age works in your favor. The placenta grows and sheds more DNA as pregnancy progresses, so fetal fraction rises steadily over time. Testing at 10 weeks sits at the lower end of the reliable range, while waiting until 12 weeks or later gives a meaningfully higher fetal fraction. For people at higher risk of a low result, some clinicians recommend delaying the blood draw until around 12 weeks.
Body weight pushes in the opposite direction. Higher maternal BMI consistently correlates with lower fetal fraction. The likely explanation is that fat tissue sheds its own cell-free DNA into the bloodstream through normal cell turnover, which increases the maternal share of the total and dilutes the placental proportion. Studies show a statistically significant difference between normal-weight and obese groups, with obese individuals having roughly half the concentration of placental material per milliliter of blood compared to normal-weight individuals. Larger blood volume in people with higher body weight may also play a role in diluting the sample.
Other factors that can lower fetal fraction include certain maternal health conditions, inflammatory states, and some medications. Twin pregnancies present a more complex picture: while the total amount of placental DNA is higher with two placentas, the per-fetus fraction for each twin is lower, which can affect screening accuracy for individual twins.
What Happens After a Low Fetal Fraction Result
If your NIPT comes back with a fetal fraction too low to interpret, the most common next step is a second blood draw. Research shows the success rate on a second attempt is about 53%, with similar odds on a third draw if needed. Two factors improve the chances of success: waiting longer between draws (success increases by roughly 4% for each additional day of waiting) and lower maternal weight (success drops by about 1.2% per kilogram of body weight).
For people whose gestational age allows it, a repeat draw a couple of weeks later gives both time and placental growth the chance to push fetal fraction above the threshold.
Low Fetal Fraction and Chromosome Conditions
A low fetal fraction isn’t just a technical inconvenience. It can itself be a signal worth paying attention to. A large meta-analysis found that low fetal fraction is associated with significantly higher odds of several chromosomal conditions. Compared to samples with normal fetal fraction, low fetal fraction samples showed roughly 6 times the odds of trisomy 13 (Patau syndrome), about 4.5 times the odds of trisomy 18 (Edwards syndrome), nearly 6 times the odds of monosomy X (Turner syndrome), and over 36 times the odds of triploidy, a condition where the fetus has a complete extra set of chromosomes.
Interestingly, low fetal fraction was not linked to higher odds of trisomy 21 (Down syndrome). The reason likely relates to placental size: some of these conditions result in a smaller, less functional placenta that releases less DNA. This is why clinical guidelines treat a no-call result as more than just a failed test and recommend follow-up evaluation.
How Labs Measure Fetal Fraction
Labs use several techniques to figure out how much of a blood sample’s DNA is placental. One common approach analyzes single-nucleotide polymorphisms, or SNPs, which are points in the genome where individuals differ by a single genetic letter. By looking at thousands of these variable sites across multiple chromosomes, the lab can model which DNA fragments came from the mother and which came from the placenta based on allele patterns. A higher fetal fraction means the minor (non-maternal) allele shows up more frequently at informative sites.
Other methods take advantage of physical differences between maternal and placental DNA. Placental DNA fragments tend to be slightly shorter than maternal ones, so fragment length analysis can estimate the proportion. Some labs use methylation patterns, which are chemical tags on DNA that differ between placental and maternal tissue. For pregnancies carrying a male fetus, the most straightforward method detects Y-chromosome DNA, which can only have come from the placenta. This Y-chromosome approach serves as a gold standard for validating other measurement techniques.